title: SEC going after insider trading based on medical research results. Securities Exchange Commission.
authors.forename: A A
authors.initials: AA
authors.lastname: Skolnick
mesh_terms: D016363:Antitrust Laws; D004345:Drug Industry / Q000191:economics*; D015507:Drugs, Investigational / Q000191:economics*; D004465:Economic Competition / Q000331:legislation & jurisprudence; D007449:Investments / Q000331:legislation & jurisprudence; D014481:United States
chemical_list: D015507:Drugs, Investigational